entdoc thanks and here is a good example of the lack of exposure to PPHM in the biotech community & Wall Street.
I have a pseudo acquaintance and friend who is brilliant. He golfs at a CC I use to frequent and I run into him at a local watering hole. Big investor in biotech and loved VICL and MNKD. He lost over a million on VICL, but had done well on MNKD and other picks. When I mentioned PPHM his response was "hey watch out for that one as management tried to cover up bad results." I was shocked because he really is a knowledgeable individual in this arena and his education is bio chem. He didn't want to hear anything about PPHM, but late last week he reached out to me. I gave him the tip around Thanksgiving, so its more then doubled. Unfortunately, we haven't connected because I've been traveling and he is down in Florida for the winter.
Furthermore, I gave this company to people at Merrill and they weren't aware of the stock. They were promoting VVUS, KERX and ARIA. Same type of response from the Merrill guys about something in the past and no knowledge of the current situation. I think most people in the biotech industry and Wall Street have left this company for dead.
I think AF is a jackass, but also hasn't bothered to look into the company in the past year. This is like our coming out party and the real story is finally being told. IMCL was a great story considering all Martha had to do was hold rather then sell. Sam and Martha go to jail and the stock hits triple digits. Like you, I think we are in a much better place then IMCL.
Those two big volume days tell me the word is getting out and accumulation is underway.
News 
Market Data 
Discover 
AI
